Brazilian photographer and environmentalist Sebastião Salgado, known for his award-winning images of nature and humanity, ...

The autologous immunotherapy consists of the patient’s own T cells engineered to express a chimeric antigen receptor that ...

Autolus Therapeutics (NASDAQ:AUTL) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed obecabtagene autoleucel for leukemia treatment. Issuing ...

A recent study from the University of Rochester's Wilmot Cancer Institute has linked taurine, an amino acid naturally produced by the body and a common ingredient in foods and energy drinks, to the ...

An international study has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn't work for everyone. The findings could help doctors better match patients with the therapies ...

A new study found that taurine could drive the growth of blood cancers like leukemia. Taurine is a common ingredient in ...

Lang's coach, Joe Fusco, was once an inspiration at hospital. "Any problem that occurs," Lang said, "I know that I have gone ...

Overall survival analysis showed median survival duration of 53.9 months (95% CI, 23.4 to not estimable) in the nivolumab arm ...

Patient age and genetic risk significantly influence remission and survival outcomes in acute myeloid leukemia (AML), a ...

Clear signs of immune activation: ICT01 at the 10 mg dose provided optimal activation of γ9δ2 T cells and a downstream immune ...

Despite global strides in targeted therapies and diagnostics, India still faces major challenges in awareness, access, and ...